Prognostic Impact of Sarcopenia's Occurrence during Radiotherapy in Oropharyngeal Cancer Patients.

HPV nutritional support oncological outcomes oropharyngeal carcinoma sarcopenia

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
24 Jan 2023
Historique:
received: 14 12 2022
revised: 16 01 2023
accepted: 19 01 2023
entrez: 11 2 2023
pubmed: 12 2 2023
medline: 12 2 2023
Statut: epublish

Résumé

The current study aims to profile sarcopenic condition (both at baseline and developed during treatment) in oropharyngeal carcinoma (OPC) patients treated with curative radiotherapy (RT) +/- chemotherapy and to evaluate its impact on oncological outcomes and toxicity. A total of 116 patients were included in this retrospective single-center study. Sarcopenia assessment at baseline and at 50 Gy re-evaluation CT was obtained from two different methodologies: (i) the L3-skeletal muscle index (SMI) derived from the contouring of the cross-sectional area (CSA) of the masticatory muscles (CSA-MM); and (ii) the paravertebral and sternocleidomastoid muscles at the level of the third cervical vertebra (CSA-C3). Based on L3-SMI from CSA-MM, developing sarcopenic condition during RT (on-RT sarcopenia) was associated with worse progression-free survival (PFS) (

Identifiants

pubmed: 36765681
pii: cancers15030723
doi: 10.3390/cancers15030723
pmc: PMC9913355
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

ORL J Otorhinolaryngol Relat Spec. 2018;80(1):1-9
pubmed: 29393251
Oral Oncol. 2014 May;50(5):380-6
pubmed: 24461628
J Clin Med. 2022 Aug 09;11(16):
pubmed: 36012884
Clin Nutr. 2021 Jan;40(1):202-206
pubmed: 32446788
Age Ageing. 2019 Jan 1;48(1):16-31
pubmed: 30312372
Curr Oncol Rep. 2020 Jul 9;22(9):91
pubmed: 32643045
Oral Oncol. 2017 Aug;71:67-74
pubmed: 28688694
Lancet Oncol. 2008 Jul;9(7):629-35
pubmed: 18539529
J Clin Oncol. 2008 Aug 1;26(22):3770-6
pubmed: 18669465
Eur Arch Otorhinolaryngol. 2019 Apr;276(4):1175-1182
pubmed: 30689037
Exp Gerontol. 2018 Sep;110:223-229
pubmed: 29928932
Head Neck. 2022 May;44(5):1047-1056
pubmed: 35138008
Lancet Oncol. 2011 May;12(5):489-95
pubmed: 21296615
JAMA Oncol. 2016 Jun 01;2(6):782-9
pubmed: 26891703
J Cachexia Sarcopenia Muscle. 2020 Apr;11(2):366-380
pubmed: 31916411
Laryngoscope Investig Otolaryngol. 2017 Jul 19;2(5):295-306
pubmed: 29094074
Acta Oncol. 2012 Apr;51(4):419-32
pubmed: 22313317
Front Oncol. 2018 Oct 22;8:457
pubmed: 30460194
Int J Radiat Oncol Biol Phys. 2019 Feb 1;103(2):353-362
pubmed: 30296472
Radiother Oncol. 2022 May;170:122-128
pubmed: 35304862
Cancer Med. 2017 Dec;6(12):2918-2931
pubmed: 29071801
Int J Part Ther. 2021 Jun 25;8(1):223-233
pubmed: 34285949
Int J Part Ther. 2021 Jun 25;8(1):108-118
pubmed: 34285940
Nutr Cancer. 2018 Oct;70(7):1051-1059
pubmed: 30273004
Cancers (Basel). 2022 Aug 17;14(16):
pubmed: 36010959
Semin Cell Dev Biol. 2016 Jun;54:2-10
pubmed: 26343952
PLoS One. 2021 May 10;16(5):e0251455
pubmed: 33970954
Cancer Manag Res. 2018 Oct 25;10:4935-4944
pubmed: 30464594
Oncologist. 2017 Sep;22(9):1056-1066
pubmed: 28533474
JAMA Otolaryngol Head Neck Surg. 2020 Aug 1;146(8):714-722
pubmed: 32525518
Radiother Oncol. 2020 Jun;147:103-110
pubmed: 32251949
Nutrition. 2017 Mar;35:114-118
pubmed: 28241978
N Engl J Med. 2008 Sep 11;359(11):1116-27
pubmed: 18784101
Oral Oncol. 2016 Nov;62:28-33
pubmed: 27865369
Clin Nutr. 2021 Apr;40(4):1711-1718
pubmed: 32994071
J Acad Nutr Diet. 2020 Aug;120(8):1330-1347.e8
pubmed: 32711854
Eur Arch Otorhinolaryngol. 2021 Jun;278(6):2001-2009
pubmed: 32772234
Oncol Lett. 2016 Feb;11(2):1230-1234
pubmed: 26893724
N Engl J Med. 2010 Jul 1;363(1):24-35
pubmed: 20530316
Cancers (Basel). 2021 Feb 11;13(4):
pubmed: 33670339
Nutrients. 2020 Oct 22;12(11):
pubmed: 33105699
J Clin Oncol. 2020 Aug 1;38(22):2552-2557
pubmed: 32496903
Sci Rep. 2022 Nov 9;12(1):19100
pubmed: 36352042
PLoS One. 2021 Jul 19;16(7):e0254844
pubmed: 34280248
Oral Oncol. 2021 Oct;121:105483
pubmed: 34403887
Nat Rev Clin Oncol. 2022 May;19(5):306-327
pubmed: 35105976
J Cachexia Sarcopenia Muscle. 2020 Feb;11(1):145-159
pubmed: 31536685
Front Oncol. 2019 Oct 15;9:1075
pubmed: 31681607
Future Oncol. 2016 Dec;12(23):2755-2764
pubmed: 27549331
Radiother Oncol. 2019 Aug;137:117-124
pubmed: 31085391
Clin Cancer Res. 2018 Oct 15;24(20):5028-5036
pubmed: 29959140
J Cachexia Sarcopenia Muscle. 2019 Oct;10(5):1060-1069
pubmed: 31134765
Support Care Cancer. 2022 Sep;30(9):7191-7204
pubmed: 35477809
BMC Cancer. 2019 Jul 9;19(1):674
pubmed: 31288767
JAMA Oncol. 2017 Dec 1;3(12):e172319
pubmed: 28796857
Ann Transl Med. 2020 Dec;8(23):1601
pubmed: 33437800
Semin Oncol. 2022 Oct;49(5):405-408
pubmed: 36241485
Front Oncol. 2022 May 12;12:884988
pubmed: 35651790
Oral Oncol. 2021 Dec;123:105617
pubmed: 34749251
Oral Dis. 2020 Oct;26(7):1384-1392
pubmed: 32315470
Curr Oncol. 2022 Nov 08;29(11):8513-8528
pubmed: 36354731
Eur J Cancer. 2016 Apr;57:58-67
pubmed: 26882087
N Engl J Med. 2006 Feb 9;354(6):567-78
pubmed: 16467544
Oral Oncol. 2017 Aug;71:26-33
pubmed: 28688687
Cureus. 2022 Feb 21;14(2):e22463
pubmed: 35345685
Curr Opin Otolaryngol Head Neck Surg. 2022 Apr 1;30(2):87-93
pubmed: 35255045
Clin Exp Otorhinolaryngol. 2019 Aug;12(3):317-324
pubmed: 30947498
Head Neck. 2014 Jun;36(6):802-10
pubmed: 23616414

Auteurs

Luca Bergamaschi (L)

Division of Radiation Oncology, European Institute of Oncology IRCCS, 20141 Milan, Italy.

Giulia Marvaso (G)

Division of Radiation Oncology, European Institute of Oncology IRCCS, 20141 Milan, Italy.
Department of Oncology and Hemato-Oncology, University of Milan, 20122 Milan, Italy.

Mattia Zaffaroni (M)

Division of Radiation Oncology, European Institute of Oncology IRCCS, 20141 Milan, Italy.

Maria Giulia Vincini (MG)

Division of Radiation Oncology, European Institute of Oncology IRCCS, 20141 Milan, Italy.

Oriana D'Ecclesiis (O)

Department of Experimental Oncology, European Institute of Oncology, IRCCS, 20141 Milan, Italy.

Stefania Volpe (S)

Division of Radiation Oncology, European Institute of Oncology IRCCS, 20141 Milan, Italy.
Department of Oncology and Hemato-Oncology, University of Milan, 20122 Milan, Italy.

Annamaria Ferrari (A)

Division of Radiation Oncology, European Institute of Oncology IRCCS, 20141 Milan, Italy.

Stefano Filippo Zorzi (SF)

Department of Otolaryngology and Head and Neck Surgery, European Institute of Oncology IRCCS, 20141 Milan, Italy.

Maria Cossu Rocca (MC)

Department of Medical Oncology, Urogenital and Head and Neck Tumors Medical Treatment, European Institute of Oncology IRCCS, 20141 Milan, Italy.

Annarita Sabbatini (A)

Dietetic and Clinical Nutrition Unit, European Institute of Oncology IRCSS, 20141 Milan, Italy.

Giulia Cannillo (G)

Dietetic and Clinical Nutrition Unit, European Institute of Oncology IRCSS, 20141 Milan, Italy.

Emanuela Zagallo (E)

Dietetic and Clinical Nutrition Unit, European Institute of Oncology IRCSS, 20141 Milan, Italy.

Anna Starzyńska (A)

Department of Oral Surgery, Medical University of Gdańsk, 80210 Gdańsk, Poland.

Mohssen Ansarin (M)

Department of Otolaryngology and Head and Neck Surgery, European Institute of Oncology IRCCS, 20141 Milan, Italy.

Federica Cattani (F)

Unit of Medical Physics, European Institute of Oncology, IRCCS, 20141 Milan, Italy.

Sara Gandini (S)

Department of Experimental Oncology, European Institute of Oncology, IRCCS, 20141 Milan, Italy.

Roberto Orecchia (R)

Unit of Medical Physics, European Institute of Oncology, IRCCS, 20141 Milan, Italy.
Scientific Directorate, European Institute of Oncology, IRCCS, 20141 Milan, Italy.

Daniela Alterio (D)

Division of Radiation Oncology, European Institute of Oncology IRCCS, 20141 Milan, Italy.

Barbara Alicja Jereczek-Fossa (BA)

Division of Radiation Oncology, European Institute of Oncology IRCCS, 20141 Milan, Italy.
Department of Oncology and Hemato-Oncology, University of Milan, 20122 Milan, Italy.

Classifications MeSH